Close Menu

NEW YORK (GenomeWeb) – Bioinformatics startup PierianDx announced today that it has partnered with Cancer Genetics to join their respective technologies into a precision oncology testing and analysis offering.

Under the alliance, the companies will combine Cancer Genetics' Focus::NGS tests — which use next-generation sequencing to provide insights into the genetics underlying solid tumors and hematologic malignancies — with PierianDx's Clinical Genomics WorkSpace software for NGS data management.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.